NANOLEK is a modern, fast-growing Russian biopharmaceutical company, specializing in the production of import-substituting and innovative drugs. Our high-tech full-cycle production facilities fully comply with GMP and ISO standards. Our portfolio features products both developed in-house and created with international partners. NANOLEK focuses on the prevention and treatment of socially significant diseases. Today, the company is a leader in the production of pediatric vaccines in Russia. NANOLEK`s diversified medicinal product portfolio features therapeutic areas including vaccines, drugs for treatment of HIV, cancer, and other diseases.